Location History:
- Indianapolis, IN (US) (1994 - 2000)
- Arlington, MA (US) (2000 - 2011)
Company Filing History:
Years Active: 1994-2011
Title: Inventor Spotlight: John D. Sharp from Arlington, MA
Introduction
John D. Sharp, an innovative inventor based in Arlington, Massachusetts, has made significant contributions to the field of biotechnology. With an impressive portfolio of 11 patents, he has focused on developing methods and compositions that have critical applications in diagnosing and treating various human and animal disorders.
Latest Patents
Among John D. Sharp's latest inventions are pivotal patents that address the modulation of activity related to TANGO332 and TANGO294. The invention concerning TANGO332 provides isolated nucleic acids that encode a variety of proteins, which are essential for diagnostic, preventive, and therapeutic uses. Moreover, these nucleic acids and proteins are advantageous for the diagnosis and treatment of various disorders. The patent encompasses antisense nucleic acid molecules, expression vectors, host cells, and non-human transgenic animals where the nucleic acid has been introduced. Additionally, it includes isolated polypeptides, fusion polypeptides, antigenic peptides, and antibodies. The diagnostic and therapeutic methods derived from this invention employ the nucleic acids and polypeptides as effective modulating agents for various cellular processes.
Similarly, the patents related to TANGO294 also focus on isolated nucleic acids and proteins with significant therapeutic potential. These inventions contribute to the understanding and modulation of cellular dynamics, offering insights that can lead to novel treatment strategies for numerous conditions.
Career Highlights
Throughout his career, John D. Sharp has played a crucial role in prestigious companies such as Millennium Pharmaceuticals Limited and Eli Lilly and Company. His work in these organizations has not only allowed him to refine his inventive skills but also to contribute to groundbreaking research that paves the way for advancements in healthcare.
Collaborations
John has had the opportunity to collaborate with notable professionals in his field, including Ruth M. Kramer and Thomas M. Barnes. These partnerships have enabled him to enhance the scope and impact of his innovative work, further solidifying his reputation as a leading inventor in biotechnological advancements.
Conclusion
John D. Sharp's dedication to innovation and his significant contributions to the field of biotechnology demonstrate the vital role inventors play in addressing medical challenges. With his ongoing research and development, he continues to pave the way for new therapeutic modalities, impacting the healthcare landscape positively.